July 16, 2024
Ghent, Belgium – Ardena (the “Company”) announces several key promotions to its executive leadership team, reflecting the Company’s commitment to driving growth and international expansion and fostering diversity and talent development.
Ariane De Ganck promoted to Division Head, Drug Product Services
Ariane De Ganck, based in Ghent, Belgium, has been promoted to Division Head, Drug Product Services. Ariane will report directly to Ardena’s CEO, Jeremie Trochu, a change that underscores her exceptional leadership and significant contributions to the company over the past 5 years. Ariane will continue to lead Ardena’s small molecule drug product development and manufacturing operations in Ghent, Belgium and Pamplona, Spain, along with Ardena’s CMC regulatory services organisation, with a clear mandate to expand internationally.
Gunnar Flik promoted to Division Head, Bioanalytical Services
Gunnar Flik, based in Assen, Netherlands, has been promoted to Division Head, Bioanalytical Services. Gunnar will also report directly to the CEO. His strategic vision combined with his innovative and entrepreneurial track record have been instrumental in the rapid expansion of Ardena’s bioanalytical services organisation. Gunnar will continue to focus on broadening the company’s bioanalytical capabilities and geographic footprint.
Gerjan Kemperman takes on dual role as COO and Division Head, Drug Substance Services
Gerjan Kemperman, based in Oss, Netherlands, will expand his current responsibilities by taking on the dual role of Chief Operating Officer (COO) and Division Head, Drug Substance Services. Gerjan will continue to report directly to the CEO. His proven track record and deep understanding of the industry make him ideally suited for this expanded role, where he will continue to drive operational excellence across company-wide functions such as IT, EHS and ESG, while leading Ardena’s drug substance development and manufacturing operations in Oss, Netherlands and Södertälje, Sweden, along with Ardena’s Nanomedicine and Solid State Research organisations, with a clear mandate to expand internationally.
These organisational changes mark the first major movements under Ardena’s new CEO and reflect the Company’s commitment to scale the organisation for its next chapter of growth and international expansion.
“By promoting talent from within and expanding our executive leadership team, we are positioning Ardena to achieve our strategic goals and drive accelerated growth on an international scale,” explains Jeremie Trochu, Ardena CEO. “We believe in recognizing and nurturing the strengths of our team members, providing them with opportunities to make meaningful contributions. These changes not only support our mission of empowerment and diversity, but also ensure that we are well-equipped to navigate our rapidly changing industry and our clients’ needs moving forward.”
